Spotted Fever Rickettsial Antigens
Spotted Fever Rickettsial Antigens
批准号:
8317699
负责人:
DAVID H WALKER
金额:
$37.37万
依托单位国家:
美国
项目类别:
财政年份:
1992
资助国家:
美国
项目状态:
已结题
起止时间:
1992-09-30 至 2014-08-31
关键词:
AccountingAcuteAdoptive TransferAgonistAnimal ModelAnti-Inflammatory AgentsAnti-inflammatoryAntibodiesAntigen-Presenting CellsAntigensApoptosisBacteriaBacterial InfectionsBiological AssayBone MarrowBrainCD4 Positive T LymphocytesCD8B1 geneCell CommunicationCell LineCell physiologyCellsCenters for Disease Control and Prevention (U.S.)Coculture TechniquesCytotoxic T-LymphocytesDendritic CellsDendritic cell activationDoseEffector CellEndothelial CellsEnzyme-Linked Immunosorbent AssayEnzymesFailureFeverFlow CytometryFrequenciesFutureGoalsGrowthHigh Pressure Liquid ChromatographyHost DefenseHumanIL2RA geneImmuneImmune responseImmunityImmunosuppressionImmunosuppressive AgentsIn VitroInfectionInfection ControlInflammatoryInterferon Type IIInterferonsInterleukin-10Interleukin-12Interleukin-2InterruptionKnockout MiceLeadLifeLigandsLigationLuciferasesLungMeasurementMediatingMental DepressionMononuclearMusMyelogenousNatural Killer CellsOutcomePathogenesisPathway interactionsPhenotypePlaque AssayProductionReceptor SignalingRecording of previous eventsRegulatory T-LymphocyteReporterReportingResearchResistanceReverse TranscriptionRickettsiaRickettsia InfectionsRocky Mountain Spotted FeverRoleSalivaSpleenSpottingsStagingStaining methodStainsSystemT cell responseT-Cell ProliferationT-LymphocyteTLR2 geneTLR3 geneTLR4 geneTicksTimeTissuesToll-like receptorsTryptophanTryptophan 2,3 DioxygenaseWorkchemokinecytokinecytotoxicdesignenzyme linked immunospot assayhuman datain vivolymphocyte proliferationmRNA Expressionmacrophagemicrobialnovelreceptorresearch studyresponse
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Severe spotted fever rickettsioses are life-threatening, tick-borne, emerging and re-emerging human infections
caused by obligately intracellular Rickettsia including R. conorii and R. rickettsii. Excellent animal models and
the available human data reveal the critical importance of IFN-gamma, CD8 cytotoxic T lymphocytes, dendritic
cells (DCs) and NK cells in host protective immunity against Rickettsia. Evidence for human rickettsial
infection-associated immunosuppression is supported by remarkable suppression of lymphocyte proliferation
and IL-2 and IFN-gamma production by IL-10 producing CD4+CD25+ T regulatory cells in acute fatal murine
spotted fever rickettsiosis compared to self-limited infection. It remains unclear why the host defense system
fails to control bacterial infection in fatal rickettsiosis. The long-term goal of this research is to better
understand the immune regulatory mechanisms involved in the inability of the host defense system to control
infection in severe spotted fever rickettsiosis. The objective of this proposal is to determine the mechanisms by
which DCs mediate defective innate and suppressed adaptive immune responses involving T regulatory 1
cells, which may lead to fatal rickettsial infection. Our specific aim 1 is to determine the key effect of impaired
DC-NK cell cross talk on promoting a defective innate immune response in severe spotted fever rickettsiosis.
We will compare the defective DC-NK cell cross talk in susceptible mice, which causes progressively increased
bacterial loads, with efficient DC-NK cell interaction in resistant mice, which lead to clearance of bacteria
during the innate response. Our specific aim 2 is to determine the role of immunoregulatory molecules such as
PD-1/PD-L and indoleamine 2,3-dioxygenase (IDO) or cytokines such as IL-10 expressed or produced by DCs
and/or T regulatory cells in suppression of T cell responses during severe spotted fever rickettsiosis. Toll-like
receptors (TLRs), cytokines and chemokines that mediate the DC-NK cell interaction in specific aim 1, and the
role of interactions of DCs with T regulatory cells in mediating suppressed protective effector type-1 T cells
and/or apoptosis via suppressive cytokines and/or regulatory molecules including PD-1/PD-L and IDO in
severe spotted fever rickettsiosis in specific aim 2 will be investigated using in vivo and in vitro approaches
including flow cytometry, ELISPOT, ELISA, RT- or real time PCR, mouse TLR PCR array,
immunohistochemical staining, plaque assay, HPLC as well as adoptive transfer, depletion of immune
molecules and knockout mice.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Vector-host-pathogen interface in monocytotropic ehrlichiosis
-
批准号:8392057
-
项目类别:
-
资助金额:$22.95万
-
财政年份:2012
-
负责人:DAVID H WALKER
-
依托单位:
Developmental Research Plan
-
批准号:8377041
-
项目类别:
-
资助金额:$44.25万
-
财政年份:2012
-
负责人:DAVID H WALKER
-
依托单位:
Career Development and Training Program
-
批准号:8377034
-
项目类别:
-
资助金额:$58.39万
-
财政年份:2012
-
负责人:DAVID H WALKER
-
依托单位:
Administrative Core
-
批准号:8377037
-
项目类别:
-
资助金额:$62.07万
-
财政年份:2012
-
负责人:DAVID H WALKER
-
依托单位:
Vector-host-pathogen interface in monocytotropic ehrlichiosis
-
批准号:8495268
-
项目类别:
-
资助金额:$17.98万
-
财政年份:2012
-
负责人:DAVID H WALKER
-
依托单位:
Developmental Research Plan
-
批准号:8233011
-
项目类别:
-
资助金额:$60.26万
-
财政年份:2011
-
负责人:DAVID H WALKER
-
依托单位:
Career Development and Training Program
-
批准号:8233007
-
项目类别:
-
资助金额:$72.59万
-
财政年份:2011
-
负责人:DAVID H WALKER
-
依托单位:
Administrative Core
-
批准号:8233008
-
项目类别:
-
资助金额:$65.25万
-
财政年份:2011
-
负责人:DAVID H WALKER
-
依托单位:
Administrative Core
-
批准号:8042570
-
项目类别:
-
资助金额:$93.69万
-
财政年份:2010
-
负责人:DAVID H WALKER
-
依托单位:
Administrative Core
-
批准号:7676462
-
项目类别:
-
资助金额:$71.89万
-
财政年份:2009
-
负责人:DAVID H WALKER
-
依托单位:
Developmental Research Plan
-
批准号:7676511
-
项目类别:
-
资助金额:$72.83万
-
财政年份:2009
-
负责人:DAVID H WALKER
-
依托单位:
Career Development and Training Program
-
批准号:7676456
-
项目类别:
-
资助金额:$72.2万
-
财政年份:2009
-
负责人:DAVID H WALKER
-
依托单位:
Western Regional Center of Excellence for Biodefense and Emerging Infectious Dise
-
批准号:7908303
-
项目类别:
-
资助金额:$93.23万
-
财政年份:2009
-
负责人:DAVID H WALKER
-
依托单位:
LASSA FEVER VACCINE EFFICACY IN MARMOSETS
-
批准号:7716083
-
项目类别:
-
资助金额:$0.27万
-
财政年份:2008
-
负责人:DAVID H WALKER
-
依托单位:
EXPERIMENTAL INFECTION OF THE MARMOSET WITH LASSA VIRUS
-
批准号:7716110
-
项目类别:
-
资助金额:$0.27万
-
财政年份:2008
-
负责人:DAVID H WALKER
-
依托单位:
LASSA FEVER BIVALENT VACCINE EFFICACY IN MARMOSETS
-
批准号:7716131
-
项目类别:
-
资助金额:$0.65万
-
财政年份:2008
-
负责人:DAVID H WALKER
-
依托单位:
REGION VI RCE - NONHUMAN PRIMATE CORE
-
批准号:7716059
-
项目类别:
-
资助金额:$2.07万
-
财政年份:2008
-
负责人:DAVID H WALKER
-
依托单位:
WRCE Administrative Core
-
批准号:7649683
-
项目类别:
-
资助金额:$60.47万
-
财政年份:2008
-
负责人:DAVID H WALKER
-
依托单位:
REGION VI RCE - NONHUMAN PRIMATE CORE
-
批准号:7562433
-
项目类别:
-
资助金额:$14.5万
-
财政年份:2007
-
负责人:DAVID H WALKER
-
依托单位:
LASSA FEVER VACCINE EFFICACY IN MARMOSETS
-
批准号:7562462
-
项目类别:
-
资助金额:$24.17万
-
财政年份:2007
-
负责人:DAVID H WALKER
-
依托单位:
海外基金